Hayward A R
Clin Exp Immunol. 1980 Jul;41(1):141-9.
Deoxyadenosine (dAdo) levels above 2 microM inhibit plasma cell (PC) differentiation by human blood lymphocytes in pokeweed mitogen (PWM) stimulated cultures containing deoxycoformycin (dCF), a potent inhibitor of adenosine deaminase (ADA). ADA inhibition by dCF alone did not suppress PC differentiation. Thymidine uptake by T cell blasts continuously cultured in conditioned medium was inhibited by dAdo and dCF; two of five EBV-infected B cell lines were also inhibited while three were resistant. Inhibition of PWM-induced PC differentiation of B cells by dCF and dAdo was reversed when conditioned medium (a source of T cell helper factors) was added to the cultures, and dAdo and dCF added to PWM-stimulated cultures 48 hr after their initiation did not inhibit PC differentiation, though thymidine uptake and the total number of cells recovered from the cultures were reduced. Removal of T cells after 48 hr of culture slightly reduced the numbers of PC in PWM-stimulated lymphocyte cultures but no further inhibition was obtained when dCF and dAdo were added to these T-depleted cultures, nor was their thymidine uptake further reduced. These results suggest that the in vitro suppression of B cell differentiation by dAdo in PWM-stimulated cultures is not due to direct toxicity of purine nucleosides to B cells but may be due to interference with T cell help. This is consistent with the view that a relative lack of helper activity by T cells contributes to the antibody deficiency of patients with ADA deficiency.
在含有强力腺苷脱氨酶(ADA)抑制剂脱氧助间型霉素(dCF)的商陆丝裂原(PWM)刺激培养体系中,脱氧腺苷(dAdo)水平高于2 microM时会抑制人血淋巴细胞的浆细胞(PC)分化。单独使用dCF抑制ADA并不会抑制PC分化。在条件培养基中持续培养的T细胞母细胞的胸苷摄取受到dAdo和dCF的抑制;五个EB病毒感染的B细胞系中有两个也受到抑制,而另外三个具有抗性。当向培养物中添加条件培养基(T细胞辅助因子的来源)时,dCF和dAdo对PWM诱导的B细胞PC分化的抑制作用会被逆转,并且在PWM刺激培养开始48小时后添加dAdo和dCF不会抑制PC分化,尽管胸苷摄取以及从培养物中回收的细胞总数会减少。培养48小时后去除T细胞会使PWM刺激的淋巴细胞培养物中的PC数量略有减少,但当向这些T细胞耗尽的培养物中添加dCF和dAdo时,不会进一步抑制,它们的胸苷摄取也不会进一步减少。这些结果表明,在PWM刺激的培养物中,dAdo对B细胞分化的体外抑制作用并非由于嘌呤核苷对B细胞的直接毒性,而是可能由于对T细胞辅助作用的干扰。这与以下观点一致,即T细胞辅助活性相对缺乏导致ADA缺乏患者的抗体缺陷。